Dose-Escalated Stereotactic Radiosurgery (SRS) Boost for Unfavorable Locally Advanced Oropharyngeal Cancer: Phase I/II Trial

Ghaly, Maged; Halthore, Aditya; Antone, J.; Zhang, H.; Cohen, Justin J.; Sachs, Harold J.; Beadle, K.; Aziz, Muhammad Hammad; Kerry-Ann, B.; Schwartz, David L.; Paul, Doru; Frank, Douglas K.; Saltman, Benjamin; Dubner, Sanford

doi:10.1016/j.ijrobp.2014.05.559

Cited by 5 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Toxicity was acceptable with one death from hemorrhage and denutrition. This study suggests that short SBRT delivery time (12 days) with cetuximab is an [8]. Patients with highrisk oropharyngeal cancer received concurrent cisplatin and 60 Gy IMRT followed by SBRT boost of 8 or 10 Gy.…”

Section: Head and Neckmentioning

confidence: 91%

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Mahadevan¹,

Bucholz²,

Gaya³

et al. 2014

Future Oncol.

View full text Add to dashboard Cite

The SRS/SBRT Scientific Meeting 2014, Minneapolis, MN, USA, 7–10 May 2014 The Radiosurgery Society®, a professional medical society dedicated to advancing the field of stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT), held the international Radiosurgery Society Scientific Meeting, from 7–10 May 2014 in Minneapolis (MN, USA). This year's conference attracted over 400 attendants from around the world and featured over 100 presentations (46 oral) describing the role of SRS/SBRT for the treatment of intracranial and extracranial malignant and nonmalignant lesions. This article summarizes the meeting highlights for SRS/SBRT treatments, both intracranial and extracranial, in a concise review.

show abstract

Section: Head and Neckmentioning

confidence: 91%

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Mahadevan¹,

Bucholz²,

Gaya³

et al. 2014

Future Oncol.

View full text Add to dashboard Cite

show abstract

“…Так, продолжается исследование I-II фаз по эскалации доз излучения с применением стереотаксиса у больных местнораспространенным ВПЧ-негативным раком ротоглотки с регионарными метастазами. [50]. Два больших ретроспективных исследования были посвящены лечению больных раком носоглотки [46,47] и одно -пациентам с опухолями ротоглотки [48].…”

Section: стереотаксическая лучевая терапия в качестве буста при лечен...unclassified

Stereotactic Body Radiation Therapy (SBRT) in Patients with Head and Neck Cancer Treatment. Current State of the Problem

Gevorkov¹,

Boyko²,

Kaprin³

2022

MEDICAL RADIOLOGY AND RADIATION SAFETY

View full text Add to dashboard Cite

This publication provides an overview of the current state of the art in the use of stereotactic radiation therapy (SBRT) for patients with head and neck tumors. We have analyzed current trends, and also presented the features of radiobiology and the basic principles of radiation treatment. Special attention is paid to indications for SBRT, fractionation schemes and radiation planning. The use of SBRT for primary head and neck tumors, including boost, as well as relapses treatment are described. The results of the implementation of SBRT by various authors both as an independent option and in combination with drug therapy are presented. The efficacy and tolerance of radiation is described in a summary form with clarifying comments. The radiation therapy toxicity profile is detailed, including the main risk factors of postradiation complications.

show abstract

Head and Neck Cancer

Eliçin¹,

Özşahin²

2017

Alternate Fractionation in Radiotherapy

View full text Add to dashboard Cite

Dose-Escalated Stereotactic Radiosurgery (SRS) Boost for Unfavorable Locally Advanced Oropharyngeal Cancer: Phase I/II Trial

Cited by 5 publications

References 0 publications

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Stereotactic Body Radiation Therapy (SBRT) in Patients with Head and Neck Cancer Treatment. Current State of the Problem

Head and Neck Cancer

Contact Info

Product

Resources

About

Dose-Escalated Stereotactic Radiosurgery (SRS) Boost for Unfavorable Locally Advanced Oropharyngeal Cancer: Phase I/II Trial

Cited by 5 publications

References 0 publications

Best of the Radiosurgery Society ® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Best of the Radiosurgery Society ® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Stereotactic Body Radiation Therapy (SBRT) in Patients with Head and Neck Cancer Treatment. Current State of the Problem

Head and Neck Cancer

Contact Info

Product

Resources

About

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions

Best of the Radiosurgery Society ^® Scientific Meeting 2014: stereotactic Radiosurgery/Stereotactic Body Radiotherapy Treatment of Extracranial and Intracranial Lesions